We are thrilled to announce that Sahi Rasa Company has been awarded the contract to supply the Parazar production line for AwaMedica Company. This collaboration marks a significant step forward in our ongoing commitment to supporting the pharmaceutical industry with high-quality materials and efficient supply chain solutions.
Scope of the Contract
As part of this agreement, our Supply Chain Management Department will take charge of providing essential materials for the production of Parazar syrup at AwaMedica’s pharmaceutical factory in Iraqi Kurdistan for a period of one year. Our responsibilities include sourcing and delivering:
- Amber glass bottles – Ensuring the safe storage and preservation of the syrup.
- P.P caps – Secure and reliable packaging components.
- Carton boxes – Protective outer packaging for transportation and distribution.
- Measuring cups – To facilitate accurate dosage for children.
- API (Active Pharmaceutical Ingredient) material – The key component in ensuring the product’s efficacy.
By managing this critical supply chain, Sahi Rasa Company is ensuring that AwaMedica can maintain uninterrupted production and distribution of Parazar syrup, a vital medication for children’s healthcare.
About ParAzar Syrup
ParAzar syrup belongs to the group of non-opioid analgesics, designed to alleviate mild to moderate pain and reduce fever. It is widely used for treating:
✔ Headaches
✔ Toothaches
✔ Colds & Flu
✔ Fever in children
Each 5 ml syrup contains 125 mg of Paracetamol BP, making it a safe and effective solution for children experiencing pain or fever. The product is packaged in a 100 ml amber glass bottle and includes a measuring cup for accurate dosing.
Strengthening Regional Pharmaceutical Capabilities
This contract reinforces Sahi Rasa Company’s role as a trusted supplier in the pharmaceutical industry. By partnering with AwaMedica, we are contributing to the growth of local pharmaceutical production and ensuring consistent access to essential medicines in the Kurdistan region.
We look forward to a successful collaboration with AwaMedica and to continuing our mission of delivering high-quality pharmaceutical solutions. Stay tuned for more updates as we embark on this exciting journey! 🚀